Diagnostic Test: Creatine Chemical Exchange Saturation Transfer (CrCEST) Imaging Sequence ( DrugBank: Creatine )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 21 | Mitochondrial disease | 1 |
21. Mitochondrial disease
Clinical trials : 33 / Drugs : 42 - (DrugBank : 32) / Drug target genes : 47 - Drug target pathways : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04734626 (ClinicalTrials.gov) | May 25, 2021 | 25/1/2021 | Muscle CrCest Muscle Phenotyping in Primary Mitochondrial Disease | Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease | Mitochondrial Diseases | Diagnostic Test: Creatine Chemical Exchange Saturation Transfer (CrCEST) Imaging Sequence | Children's Hospital of Philadelphia | NULL | Recruiting | 7 Years | 75 Years | All | 40 | United States |